1-WEEK Hypofractionated Adjuvant Whole-Breast Radiotherapy: Towards a New Standard? (original) (raw)

Hypofractionated adjuvant whole-breast radiotherapy is explored as a new standard in treating early-stage breast cancer. This study reports on the long-term results of the FAST-Forward trial, comparing different hypofractionated regimens to traditional methods. The findings suggest that a 26 Gy treatment in five fractions can be a safe and effective alternative, with no significant differences in relapse and survival rates, although considerations of toxicity, patient demographics, and treatment methodologies underscore the complexities involved.